TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

NEJM: Safety and Efficacy of the BNT162b2 MRNA Covid-19 Vaccine

3 点作者 rediguanayum超过 4 年前

1 comment

divbzero超过 4 年前
It’s curious that the most complete peer-reviewed report on the Pfizer-BioNTech COVID-19 vaccine got less attention on HN than the press releases about the trial and approval process. I’m sure it’s largely luck of the draw but it would have been cool to see more discussion here.<p>In particular, Figure 2 could be of interest to anyone receiving this vaccine as it provides a detailed breakdown of % participants experiencing various side effects.